Authors: Galvez, A Ocaranza, MP Lavandero, S Jalil, JE

Citation: A. Galvez et al., Early prevention of experimental left ventricular hypertrophy in experimental hypertension and angiotensin II levels, REV ESP CAR, 54(11), 2001, pp. 1287-1294

Authors: Oliveri, C Ocaranza, MP Campos, X Lavandero, S Jalil, JE

Citation: C. Oliveri et al., Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat, HYPERTENSIO, 38(3), 2001, pp. 650-654

Authors: Jalil, JE Piddo, AM Cordova, S Chamorro, G Braun, S Jalil, R Vega, J Jadue'P, L Lavandero, S Lastra, P

Citation: Je. Jalil et al., Prevalence of the angiotensin I converting enzyme insertion deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population, AM J HYPERT, 12(7), 1999, pp. 697-704

Authors: Castro, PF Bourge, RC Jalil, JE Martinez, JA

Citation: Pf. Castro et al., Selection and evaluation of patients for cardiac transplantation, REV ESP CAR, 52(8), 1999, pp. 604-616

Authors: Jalil, JE Ebensperger, R Melendez, J Acevedo, E Sapag-Hagar, M Gonzalez-Jara, F Galvez, A Perez-Montes, V Lavandero, S

Citation: Je. Jalil et al., Effects of antihypertensive treatment on cardiac IGF-1 during prevention of ventricular hypertrophy in the rat, LIFE SCI, 64(18), 1999, pp. 1603-1612

Authors: Jalil, JE Ocaranza, MP Piddo, AM Jalil, R

Citation: Je. Jalil et al., Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyl-leucine assubstrate, J LA CL MED, 133(5), 1999, pp. 501-506